Product Details for NDA 050467
DOXORUBICIN HYDROCHLORIDE (DOXORUBICIN HYDROCHLORIDE)
10MG/VIAL
Marketing Status: Discontinued
20MG/VIAL
Marketing Status: Discontinued
50MG/VIAL
Marketing Status: Discontinued
150MG/VIAL
Marketing Status: Discontinued
10MG/VIAL
Marketing Status: Discontinued
Active Ingredient: DOXORUBICIN HYDROCHLORIDE
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information
DOXORUBICIN HYDROCHLORIDE (DOXORUBICIN HYDROCHLORIDE)
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information
20MG/VIAL
Marketing Status: Discontinued
Active Ingredient: DOXORUBICIN HYDROCHLORIDE
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 003
Approval Date: May 20, 1985
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information
DOXORUBICIN HYDROCHLORIDE (DOXORUBICIN HYDROCHLORIDE)
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 003
Approval Date: May 20, 1985
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information
50MG/VIAL
Marketing Status: Discontinued
Active Ingredient: DOXORUBICIN HYDROCHLORIDE
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information
DOXORUBICIN HYDROCHLORIDE (DOXORUBICIN HYDROCHLORIDE)
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information
150MG/VIAL
Marketing Status: Discontinued
Active Ingredient: DOXORUBICIN HYDROCHLORIDE
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 150MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 004
Approval Date: Jul 22, 1987
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: DOXORUBICIN HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 150MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050467
Product Number: 004
Approval Date: Jul 22, 1987
Applicant Holder Full Name: PFIZER INC
Marketing Status: Discontinued
Patent and Exclusivity Information